2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol-d5

2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol-d5

• UNSPSC Description: 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol-d5 (2,4-Diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine-d5) is deuterium labeled 2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Smiles: CCCCCCOC1=CC=C(C(O)=C1)C2=NC(C3=C([2H])C([2H])=C([2H])C([2H])=C3[2H])=NC(C4=CC=CC=C4)=N2
• Molecular Weight: 430.55
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported